Pfizer | PFE

Stock Price
25.26
Daily Change
-0.97 -3.69%
Monthly
-8.45%
Yearly
-34.61%
Q2 Forecast
27.22
Peers Price Chg Day Year Date
ABBV AbbVie 167.20 -0.81 -0.48% 3.34% Apr/25
ABT Abbott 106.90 -0.06 -0.06% -1.70% Apr/25
ALKS ALKERMES 24.44 0.37 1.52% -13.90% Apr/25
AMGN Amgen 269.42 -3.72 -1.36% 12.82% Apr/25
AZN AstraZeneca 11,968.00 -58.00 -0.48% 1.46% Apr/26
BAYN Bayer 27.34 0.44 1.64% -54.23% Apr/26
BIIB Biogen 202.49 0.36 0.18% -29.70% Apr/25
BMY Bristol-Myers Squibb 44.70 -4.16 -8.51% -34.28% Apr/25
CTLT Catalent 55.80 -0.14 -0.25% 31.73% Apr/25
GILD Gilead Sciences 65.07 -1.83 -2.73% -22.30% Apr/25
GSK GlaxoSmithKline 1,634.50 -6.00 -0.37% 13.74% Apr/26
GSK Glaxosmithkline 40.91 0.05 0.12% 13.86% Apr/25
JNJ J&J 146.84 -1.73 -1.16% -9.70% Apr/25
LLY Eli Lilly 729.01 -8.11 -1.11% 93.75% Apr/25
MDT Medtronic 79.06 -1.21 -1.50% -12.13% Apr/25
MRK Merck 130.49 3.59 2.83% 15.04% Apr/25
NBIX Neurocrine Biosciences 137.73 -1.24 -0.89% 34.08% Apr/25
NOVN Novartis 89.37 -0.63 -0.70% -2.17% Apr/26
NVS Novartis 99.12 0.74 0.75% -3.34% Apr/25
PBH Prestige Brands 70.14 0.01 0.01% 14.81% Apr/25
PCRX Pacira 25.50 -0.40 -1.54% -42.14% Apr/25
PFE Pfizer 25.26 -0.97 -3.69% -34.61% Apr/25
PRGO Perrigo 31.26 0.03 0.10% -13.28% Apr/25
RDY Drreddys Laboratories 74.02 3.10 4.37% 24.47% Apr/25
REGN Regeneron Pharmaceuticals 906.54 -16.99 -1.87% 16.52% Apr/25
ROG Roche Holding 219.40 0.60 0.27% -20.56% Apr/26
SAN Sanofi 89.66 -1.96 -2.14% -11.94% Apr/26
SNY Sanofi 49.33 2.77 5.95% -12.26% Apr/25
VRTX Vertex Pharmaceuticals 397.24 -3.35 -0.84% 22.87% Apr/25
ZTS Zoetis 153.44 2.51 1.66% -11.28% Apr/25

Indexes Price Day Year Date
SPX US500 5048 -23.21 -0.46% 22.08% Apr/26

Pfizer traded at $25.26 this Thursday April 25th, decreasing $0.97 or 3.69 percent since the previous trading session. Looking back, over the last four weeks, Pfizer lost 8.45 percent. Over the last 12 months, its price fell by 34.61 percent. Looking ahead, we forecast Pfizer to be priced at 27.22 by the end of this quarter and at 25.69 in one year, according to Trading Economics global macro models projections and analysts expectations.

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.